Management and educational status of adult anaphylaxis patients at emergency department
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: We evaluated the management and educational status of adult anaphylaxis patients at emergency departments (EDs). Methods: Anaphylaxis patients who visited ED from 2011 to 2013 were enrolled from three hospitals. We analyzed clinical features, prior history of anaphylaxis, management and provided education for etiology and/or prevention. For analyzing associated factors with epinephrine injection, Pearson chi-square test was used by SPSS version 21 (IBM Co.). Results: A total of 194 anaphylaxis patients were enrolled. Ninety-nine patients (51%) visited ED by themselves. Time interval from symptom onset to ED visit was 62 ± 70.5 minutes. Drug (56.2%) was the most frequent cause of anaphylaxis. Forty-seven patients (24.2%) had prior history of anaphylaxis and 33 patients had same suspicious cause with current anaphylaxis. Cutaneous (88.7%) and respiratory (72.7%) symptoms were frequent. Hypotension was presented in 114 patients (58.8%). Mean observation time in ED was 12 ± 25.7 hours and epinephrine was injected in 114 patients (62%). In 68 patients, epinephrine was injected intramuscularly with mean dose of 0.3 ± 0.10 mg. Associated factor with epinephrine injection was hypotension (p = 0.000). Twenty-three patients (13%) were educated about avoidance of suspicious agent. Epinephrine auto-injectors were prescribed only in five patients. Only 34 (19%) and 72 (40%) patients were consulted to allergist at ED and outpatient allergy department respectively. Conclusions: We suggested that management and education of anaphylaxis were not fully carried out in ED. An education and promotion program on anaphylaxis is needed for medical staff.
Abstract
Background/Aims: We evaluated the management and educational status of adult anaphylaxis patients at emergency departments (EDs). Methods: Anaphylaxis patients who visited ED from 2011 to 2013 were enrolled from three hospitals. We analyzed clinical features, prior history of anaphylaxis, management and provided education for etiology and/or prevention. For analyzing associated factors with epinephrine injection, Pearson chi-square test was used by SPSS version 21 (IBM Co.). Results: A total of 194 anaphylaxis patients were enrolled. Ninety-nine patients (51%) visited ED by themselves. Time interval from symptom onset to ED visit was 62 ± 70.5 minutes. Drug (56.2%) was the most frequent cause of anaphylaxis. Forty-seven patients (24.2%) had prior history of anaphylaxis and 33 patients had same suspicious cause with current anaphylaxis. Cutaneous (88.7%) and respiratory (72.7%) symptoms were frequent. Hypotension was presented in 114 patients (58.8%). Mean observation time in ED was 12 ± 25.7 hours and epinephrine was injected in 114 patients (62%). In 68 patients, epinephrine was injected intramuscularly with mean dose of 0.3 ± 0.10 mg. Associated factor with epinephrine injection was hypotension (p = 0.000). Twenty-three patients (13%) were educated about avoidance of suspicious agent. Epinephrine auto-injectors were prescribed only in five patients. Only 34 (19%) and 72 (40%) patients were consulted to allergist at ED and outpatient allergy department respectively. Conclusions: We suggested that management and education of anaphylaxis were not fully carried out in ED. An education and promotion program on anaphylaxis is needed for medical staff.
참고문헌 (13)
- Brown SG, "Anaphylaxis: clinical patterns, mediator release, and severity", J Allergy Clin Immunol, 132, pp.1141~1149 (2013)[DOI]
- Simons FE, "World Allergy Organization guidelines for the assessment and management of anaphylaxis", World Allergy Organ J, 4, pp.13~37 (2011)[DOI]
- Lieberman P, "Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group", Ann Allergy Asthma Immunol, 97, pp.596~602 (2006)[DOI]
- 예영민, "Predictors of the Severity and Serious Outcomes of Anaphylaxis in Korean Adults: A Multicenter Retrospective Case Study", Allergy, Asthma & Immunology Research, 7(1), pp.22~29 (2015), 대한천식알레르기학회
- Simons FE, "2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis", Curr Opin Allergy Clin Immunol, 12, pp.389~399 (2012)[DOI]
- Yang MS, "Epidemiologic and clinical features of anaphylaxis in Korea", Ann Allergy Asthma Immunol, 100, pp.31~36 (2008)[DOI]
- 장광천, "한국 아나필락시스의 진료", Allergy Asthma & Respiratory Disease, 1(3), pp.181~196 (2013), 대한 소아알레르기 호흡기학회
- 문일주, "단일 3차 의료 기관의 약물 유발 아나필락시스 발생 현황", 대한내과학회지, 88(3), pp.281~287 (2015), 대한내과학회[DOI]
- Campbell RL, "Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine", J Allergy Clin Immunol Pract, 3, pp.76~80 (2015)[DOI]
- [URL]
- Simons FE, "World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base", Int Arch Allergy Immunol, 162, pp.193~204 (2013)[DOI]
- Campbell RL, "Outcomes of allergy", immunology follow-up after an emergency department evaluation for anaphylaxis, 2015, pp.3, 88~93
- Sclar DA, "Anaphylaxis: underdiagnosed, underreported, and undertreated", Am J Med, 127(1 Suppl), pp.S1~S5 (2014)[DOI]